Altace Alternatives Compared
Altace (ramipril) | Ozempic (semaglutide) | Wegovy (semaglutide) |
|
---|
Altace (ramipril) | Ozempic (semaglutide) | Wegovy (semaglutide) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for High Blood Pressure, Left Ventricular Dysfunction, Diabetic Kidney Disease, Heart Failure, Cardiovascular Risk Reduction, Heart Attack. Altace may also be used for purposes not listed... View more |
Prescription only
Ozempic lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the liver. It is... View more |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction. Wegovy may also be used for purposes not listed in this medication guide. |
Related suggestions Cardiovascular Risk Reduction
|
|||||||||||||||
More about Altace (ramipril) | More about Ozempic (semaglutide) | More about Wegovy (semaglutide) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Altace has an average rating of 6.9 out of 10 from a total of 12 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Ozempic has an average rating of 6.7 out of 10 from a total of 1567 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 23% reported a negative effect. |
Wegovy has an average rating of 7.6 out of 10 from a total of 516 ratings on Drugs.com. 66% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
View all Altace side effects |
View all Ozempic side effects |
View all Wegovy side effects |
||||||||||||||||
Drug Class | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Altace prices |
View all Ozempic prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Other semaglutide brands include: Rybelsus, Wegovy | Other semaglutide brands include: Ozempic, Rybelsus | ||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
50 hours |
168 hours |
168 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 402 drugs are known to interact with Altace:
|
A total of 275 drugs are known to interact with Ozempic:
|
A total of 275 drugs are known to interact with Wegovy:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
January 28, 1991 |
N/A |
N/A |
||||||||||||||||
WADA Class View classifications | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient Resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.